BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7691609)

  • 1. Regulation of CD59 expression on the human endothelial cell line EA.hy 926.
    Meri S; Mattila P; Renkonen R
    Eur J Immunol; 1993 Oct; 23(10):2511-6. PubMed ID: 7691609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis.
    Brooimans RA; Van der Ark AA; Tomita M; Van Es LA; Daha MR
    Eur J Immunol; 1992 Mar; 22(3):791-7. PubMed ID: 1372260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
    Hakulinen J; Meri S
    Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
    Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.
    Marchbank KJ; Morgan BP; van den Berg CW
    Immunology; 1995 May; 85(1):146-52. PubMed ID: 7543447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues.
    Meri S; Waldmann H; Lachmann PJ
    Lab Invest; 1991 Nov; 65(5):532-7. PubMed ID: 1721667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S; van den Berg CW
    Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
    Väkevä A; Laurila P; Meri S
    Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester.
    Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA
    J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of complement activation on the expression of CD59 by human mesangial cells.
    Shibata T; Kohsaka T
    J Immunol; 1995 Jul; 155(1):403-9. PubMed ID: 7541422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-induced expression of the competence gene KC in vascular endothelial cells is mediated through protein kinase C.
    Shen XY; Hamilton TA; DiCorleto PE
    J Cell Physiol; 1989 Jul; 140(1):44-51. PubMed ID: 2472419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
    Chen S; Caragine T; Cheung NK; Tomlinson S
    Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein upregulates complement-inhibitory factors in endothelial cells.
    Li SH; Szmitko PE; Weisel RD; Wang CH; Fedak PW; Li RK; Mickle DA; Verma S
    Circulation; 2004 Feb; 109(7):833-6. PubMed ID: 14967730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of the complement-regulatory factor C8 binding protein (C8bp) on U937 cells after stimulation with IL-1 beta, endotoxin, IFN-gamma, or phorbol ester.
    Schieren G; Janssen O; Hänsch GM
    J Immunol; 1992 May; 148(10):3183-8. PubMed ID: 1578143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.